Craig Hopkinson M.D.
About Craig Hopkinson M.D.
Craig Hopkinson M.D. is the EVP, Research and Development, and CMO at Alkermes, with over 25 years of experience in clinical development and medical affairs.
Professional Background
Craig Hopkinson, M.D. is currently the EVP of Research and Development as well as the CMO at Alkermes, based in Waltham, Massachusetts. Since joining Alkermes in May 2018, he has held leadership roles in Clinical Development and Medical Affairs. His professional journey includes tenure as SVP and Head of Global Medical Affairs at Vertex Pharmaceuticals from 2014 to 2017 and several senior leadership roles at Eisai Pharmaceuticals, including President of various units focused on value maximization and frontiers in product creation.
Career Expertise
Craig Hopkinson, M.D. brings over 25 years of experience in building and leading clinical development organizations and medical affairs groups. With a specialization in multiple therapeutic areas, he has expertise in Cardiovascular, Oncology, Gastroenterology, Neurology, Psychiatry, and Immunology. Furthermore, he has led multidisciplinary development teams in therapeutic areas such as neuroscience, oncology, infectious diseases, and genetic diseases.
Prior Leadership Roles
Before his current role at Alkermes, Craig Hopkinson, M.D. served as Senior Vice President of Medicines Development and Head of Global Medical Affairs at Vertex Pharmaceuticals. He also occupied key leadership roles at Eisai Pharmaceuticals, including President of Eisai Value Maximization Systems and President of the Frontier Product Creation Unit. Additionally, he has held positions at prestigious firms such as Pfizer, Actelion Pharmaceuticals, Elan Pharmaceuticals, and Pharmacia.
Education and Medical Training
Craig Hopkinson, M.D. earned his medical degree (MD) from the University of the Free State, where he studied from 1985 to 1992. He also holds a Bachelor of Medicine and a Bachelor of Surgery from the University of the Orange Free State in South Africa. His extensive educational background has provided him a robust foundation for his diversified career in medical research and pharmaceutical development.